Lynx1 Capital Management LP: 13F holdings
CIK 19104562026Q2
| Positions | 27 |
|---|
| Reported value | $865.5m |
|---|
| Filed | 2026-08-13 |
|---|
Change since last quarter
| Positions | 27 (+4 vs prior quarter) |
|---|
| Reported value | $865.5m (+36.8%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| GH RESEARCH PLC | 13,263,288 | $356.5m | 41.2% |
| CGEM CULLINAN THERAPEUTICS INC | 8,963,500 | $163.2m | 18.9% |
| STOK STOKE THERAPEUTICS INC | 4,038,404 | $132.1m | 15.3% |
| AGIO AGIOS PHARMACEUTICALS INC | 3,408,937 | $126.5m | 14.6% |
| CCCC C4 THERAPEUTICS INC | 7,326,691 | $34.2m | 4.0% |
| KRRO KORRO BIO INC | 1,538,296 | $20.3m | 2.3% |
| TSCAN THERAPEUTICS INC | 8,019,148 | $7.9m | 0.9% |
| PRECISION BIOSCIENCES INC | 950,466 | $7.5m | 0.9% |
| NEUPHORIA THERAPEUTICS INC | 875,328 | $3.8m | 0.4% |
| PASSAGE BIO INC | 673,759 | $3.3m | 0.4% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1910456")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples